Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Human antigen R binding and regulation of SOX2 mRNA in human mesenchymal stem cells.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
[The chronic form of tick-born encephalitis with a clinical manifestation of disseminated encephalomyelitis (case description).]
Expansion of CD27(high) plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.
B lymphocytes in neuromyelitis optica.
Risk of relapse phenotype recurrence in multiple sclerosis.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
Low and High CD8 Positive T cells in Multiple Sclerosis Patients.
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Does natalizumab therapy worsen neuromyelitis optica?
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
[2012: news in neurology].
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.

Pages